These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32709909)

  • 1. Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion.
    Simon D; Tascilar K; Krönke G; Kleyer A; Zaiss MM; Heppt F; Meder C; Atreya R; Klenske E; Dietrich P; Abdullah A; Kliem T; Corte G; Morf H; Leppkes M; Kremer AE; Ramming A; Pachowsky M; Schuch F; Ronneberger M; Kleinert S; Maier C; Hueber AJ; Manger K; Manger B; Berking C; Tenbusch M; Überla K; Sticherling M; Neurath MF; Schett G
    Nat Commun; 2020 Jul; 11(1):3774. PubMed ID: 32709909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a COVID-19 outbreak.
    Veenstra J; Buechler CR; Robinson G; Chapman S; Adelman M; Tisack A; Dimitrion P; Todter E; Kohen L; Lim HW
    J Am Acad Dermatol; 2020 Dec; 83(6):1696-1703. PubMed ID: 32735965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort.
    Simon D; Tascilar K; Kleyer A; Fagni F; Krönke G; Meder C; Dietrich P; Orlemann T; Kliem T; Mößner J; Liphardt AM; Schönau V; Bohr D; Schuster L; Hartmann F; Leppkes M; Ramming A; Pachowsky M; Schuch F; Ronneberger M; Kleinert S; Hueber AJ; Manger K; Manger B; Atreya R; Berking C; Sticherling M; Neurath MF; Schett G
    Arthritis Rheumatol; 2022 May; 74(5):783-790. PubMed ID: 34951137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit.
    Hains DS; Schwaderer AL; Carroll AE; Starr MC; Wilson AC; Amanat F; Krammer F
    JAMA; 2020 Jun; 323(23):2424-2425. PubMed ID: 32407440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.
    Chen SY; Lee YL; Lin YC; Lee NY; Liao CH; Hung YP; Lu MC; Wu JL; Tseng WP; Lin CH; Chung MY; Kang CM; Lee YF; Lee TF; Cheng CY; Chen CP; Huang CH; Liu CE; Cheng SH; Ko WC; Hsueh PR; Chen SC
    Emerg Microbes Infect; 2020 Dec; 9(1):2157-2168. PubMed ID: 32940547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: A prospective longitudinal study.
    Fill Malfertheiner S; Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M; Häusler S
    J Clin Virol; 2020 Sep; 130():104575. PubMed ID: 32805631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional study of immune seroconversion to SARS-CoV-2 in frontline maternity health professionals.
    Bampoe S; Lucas DN; Neall G; Sceales P; Aggarwal R; Caulfield K; Siassakos D; Odor PM
    Anaesthesia; 2020 Dec; 75(12):1614-1619. PubMed ID: 32777861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.
    Sood N; Simon P; Ebner P; Eichner D; Reynolds J; Bendavid E; Bhattacharya J
    JAMA; 2020 Jun; 323(23):2425-2427. PubMed ID: 32421144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of IgG and IgM antibody response in COVID-19 patients.
    Liu X; Wang J; Xu X; Liao G; Chen Y; Hu CH
    Emerg Microbes Infect; 2020 Dec; 9(1):1269-1274. PubMed ID: 32515684
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphopenia in COVID-19: Therapeutic opportunities.
    Fathi N; Rezaei N
    Cell Biol Int; 2020 Sep; 44(9):1792-1797. PubMed ID: 32458561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
    J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses to SARS-CoV-2 in patients with COVID-19.
    Long QX; Liu BZ; Deng HJ; Wu GC; Deng K; Chen YK; Liao P; Qiu JF; Lin Y; Cai XF; Wang DQ; Hu Y; Ren JH; Tang N; Xu YY; Yu LH; Mo Z; Gong F; Zhang XL; Tian WG; Hu L; Zhang XX; Xiang JL; Du HX; Liu HW; Lang CH; Luo XH; Wu SB; Cui XP; Zhou Z; Zhu MM; Wang J; Xue CJ; Li XF; Wang L; Li ZJ; Wang K; Niu CC; Yang QJ; Tang XJ; Zhang Y; Liu XM; Li JJ; Zhang DC; Zhang F; Liu P; Yuan J; Li Q; Hu JL; Chen J; Huang AL
    Nat Med; 2020 Jun; 26(6):845-848. PubMed ID: 32350462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
    den Hartog G; Schepp RM; Kuijer M; GeurtsvanKessel C; van Beek J; Rots N; Koopmans MPG; van der Klis FRM; van Binnendijk RS
    J Infect Dis; 2020 Oct; 222(9):1452-1461. PubMed ID: 32766833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19.
    Liu T; Zeng G; Tao H; Shi Y; ; Wang T; Liu T; Guo F; Zhou F; Wang X
    Int J Cancer; 2020 Dec; 147(11):3267-3269. PubMed ID: 32525566
    [No Abstract]   [Full Text] [Related]  

  • 17. Serosurvey of SARS-CoV-2 among hospital visitors in China.
    Liang W; Lin Y; Bi J; Li J; Liang Y; Wong SS; Zanin M; Yang Z; Li C; Zhong R; Jiang G; Han G; Hu D; He J; Zhong N
    Cell Res; 2020 Sep; 30(9):817-818. PubMed ID: 32686766
    [No Abstract]   [Full Text] [Related]  

  • 18. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
    J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test.
    Dortet L; Emeraud C; Vauloup-Fellous C; Khecharem M; Ronat JB; Fortineau N; Roque-Afonso AM; Naas T
    Emerg Microbes Infect; 2020 Dec; 9(1):2212-2221. PubMed ID: 32969769
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.
    Ibarrondo FJ; Fulcher JA; Goodman-Meza D; Elliott J; Hofmann C; Hausner MA; Ferbas KG; Tobin NH; Aldrovandi GM; Yang OO
    N Engl J Med; 2020 Sep; 383(11):1085-1087. PubMed ID: 32706954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.